BAX ownership: Pzena Investment Management files 13G for 39.7M shares
Rhea-AI Filing Summary
Pzena Investment Management LLC filed Amendment No. 1 to its Schedule 13G on 15 July 2025, disclosing beneficial ownership of 39,708,226 shares of Baxter International Inc. (BAX) common stock, equal to 7.7 % of the outstanding class as of 30 June 2025.
The New York–based investment adviser reports sole voting power over 33,062,441 shares and sole dispositive power over the full 39.7 million shares; no shares are subject to shared voting/dispositive control. The filing states that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of Baxter.
This disclosure signals that a well-known value-oriented institutional investor maintains a sizable position above the 5 % threshold, information that may influence perceptions of Baxter’s shareholder base and potential governance dynamics. However, the filing contains no operational or financial performance data and does not indicate any activist intent.
Positive
- Institutional confidence: A respected value-focused adviser reports a sizable 7.7 % stake in BAX, which may be viewed as a vote of confidence by some investors.
Negative
- None.
Insights
TL;DR – Pzena now holds 7.7 % of BAX; neutral unless activist stance emerges.
The amended 13G reveals that Pzena Investment Management increased or confirmed its stake to nearly 40 million shares, giving it 7.7 % of Baxter’s common stock. Because the form is filed under Rule 13d-1(b) as an investment adviser, the firm certifies it is passive; there is no indication of plans to influence control. For investors, the disclosure adds transparency, highlights concentrated institutional ownership, and could marginally improve market sentiment by demonstrating confidence from a respected value manager. Absent activism or a material ownership swing versus prior filings, the update is informational rather than catalytic.